<DOC>
	<DOCNO>NCT00489853</DOCNO>
	<brief_summary>The purpose study investigate effect exercise tolerance , lung function symptom treatment Symbicort , Oxis placebo patient severe chronic obstructive pulmonary disease .</brief_summary>
	<brief_title>Evaluation Efficacy Exercise Tolerance Symbicort ( Budesonide/Formoterol ) Compared Placebo Oxis Patients With Severe COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>&gt; =40 year age diagnose COPD symptom &gt; = 2 year prebronchodilatory FEV1 &lt; =50 % PN Current respiratory tract disorder COPD history asthma rhinitis significant unstable cardiovascular disorder</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>COPD</keyword>
</DOC>